Nexstim joins 2014 Red Herring mark of distinction

NewsGuard 100/100 Score

Red Herring's Top 100 Europe celebrates the exceptional accomplishments of technology companies and their position to grow at an explosive rate. The awards winners were announced today, and Nexstim has proudly been selected in this prestigious group as a Top 100 Europe.

"I'm very excited about this award and recognition of our work to get help for patients with this remarkable technology we have developed" said Janne Huhtala, CEO of Nexstim. "I am honored to work with Nexstim's very skillful people who have made this happen."

Since 1996, the Red Herring 100 winners have been recognizing the most exciting startups from around the globe. Nexstim is honored to join this mark of distinction, which identifies promising new companies. We join a long list of outstanding companies such as Facebook, Twitter, Google, Yahoo, Skype, Salesforce.com, YouTube, and eBay.

"Selecting startups that show the most potential for disruption and growth is never easy," said Alex Vieux, publisher and CEO of Red Herring. "We looked at hundreds and hundreds of candidates from all across the continent, and after much thought and debate, narrowed the list down to the Top 100 Winners. Each year, the competition gets tougher but we believe Nexstim demonstrates the vision, drive and innovation that define a Red Herring winner."

Red Herring's editorial team makes their selection through an evaluation of both quantitative and qualitative criteria, such as level of specialty, social contribution, international footprint, growth rate, and technological advantages. The executive team assesses a company's track record and industry standing in the same industry sector, making the list a valuable instrument of discovery and advocacy for the most promising new businesses in Europe.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study reveals lifestyle factors boosting IVF success